- Imatinib, sold
under the
brand names Gleevec and
Glivec (both
marketed worldwide by Novartis)
among others, is an oral
targeted therapy medication used...
-
carbamazepine (Tegretol),
valsartan (Diovan),
imatinib mesylate (Gleevec/
Glivec),
cyclosporine (Neoral/Sandimmune),
letrozole (Femara), methylphenidate...
-
develop this disease. It is
treated with
imatinib (Gleevec in
United States,
Glivec in Europe) or
other drugs. The five-year
survival rate is 90%. One subtype...
- India—roughly 16,000 people—receive
Glivec free of charge... and it has
provided more than $1.7
billion worth of
Glivec to
Indian patients in its support...
-
formulation that can
substitute Glivec, were
distributed in the
local market since 1993.
Novartis had
filed a
patent for
Glivec in 1997. An
exclusive marketing...
-
Glivec in Europe).
Other pharmacological inhibitors are
being developed,
which are more
potent and/or are
active against the
emerging Gleevec/
Glivec resistant...
-
Pharma launched Veenat, a
generic version of
Novartis AG's anti-cancer drug
Glivec. It won the
subsequent patent protection legal battle against Novartis in...
-
fight against drug
maker Novartis on the
issue of
patent of
cancer drug
Glivec. On the
night before Yakub Memon was
scheduled to be executed,
Anand Grover...
- of
medicines to
patients affected by leprosy, tuberculosis, and malaria;
Glivec patient ****istance programs; and
relief to
support major humanitarian organisations...
- Novo
Nordisk Diabetes mellitus type 1 and 2 Dec-1990 Mon-20XX 26 Gleevec,
Glivec Imatinib 498,149 7.22%
Novartis Leukemia May-2001 Jan-2015 27 Herceptin...
